US 7241739
Morphogenic protein
granted A61KA61K38/00A61P
Quick answer
US patent 7241739 (Morphogenic protein) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61P, A61P19/00, A61P43/00